Literature DB >> 25453780

An accidental poisoning with mitragynine.

Ritva Karinen1, Jan Toralf Fosen2, Sidsel Rogde3, Vigdis Vindenes2.   

Abstract

An increasing number of drugs of abuse are sold word wide over the internet. Names like "legal highs", "herbal highs" etc. give the impression that these are safe products, although the risk of fatal reactions might be substantial. Leaves from the plant Mitragyna speciosa, contain active compounds like mitragynine and 7-hydroxymitragynine. It has been reported that the potency of 7-hydroxymitragynine at the μ-opioid receptor is 30 times higher than that of mitragynine and 17 times higher than that of morphine. Case reports regarding poisoning with Kratom are reported, but the toxic or lethal ranges for the concentrations of the active substances have not been established, and concentrations of 7-hydroxymitragynine have not been reported previously. We present a case report where a middle aged man was found dead at home. The deceased had a history of drug abuse and mental illness for several years. At autopsy, there were no significant pathological findings. Post-mortem analysis of peripheral blood revealed: zopiclone 0.043mg/L, citalopram 0.36mg/L and lamotrigine 5.4mg/L, i.e. concentrations regularly seen after therapeutic ingestion of these drugs. Additionally mitragynine 1.06mg/L and 7-hydroxymitragynine 0.15mg/L were detected in blood and both also in urine. The high concentrations of mitragynine and 7-hydroxymitragynine indicate that the cause of death is intoxication by these substances; and the circumstances point toward the manner of death being accidental. We recommend that both mitragynine and 7-hydroxymitragynine are analyzed for in cases with suspected Kratom intoxication.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  7-Hydroxymitragynine; Blood drug concentration; Drug fatality; Forensic toxicology; Mitragynine; UPLC–MS/MS

Mesh:

Substances:

Year:  2014        PMID: 25453780     DOI: 10.1016/j.forsciint.2014.10.025

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  15 in total

1.  The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids.

Authors:  Laura Flores-Bocanegra; Huzefa A Raja; Tyler N Graf; Mario Augustinović; E Diane Wallace; Shabnam Hematian; Joshua J Kellogg; Daniel A Todd; Nadja B Cech; Nicholas H Oberlies
Journal:  J Nat Prod       Date:  2020-06-29       Impact factor: 4.050

Review 2.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

3.  Novel case of maternal and neonatal kratom dependence and withdrawal.

Authors:  Lindsay Mackay; Ronald Abrahams
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

4.  Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.

Authors:  András Váradi; Gina F Marrone; Travis C Palmer; Ankita Narayan; Márton R Szabó; Valerie Le Rouzic; Steven G Grinnell; Joan J Subrath; Evelyn Warner; Sanjay Kalra; Amanda Hunkele; Jeremy Pagirsky; Shainnel O Eans; Jessica M Medina; Jin Xu; Ying-Xian Pan; Attila Borics; Gavril W Pasternak; Jay P McLaughlin; Susruta Majumdar
Journal:  J Med Chem       Date:  2016-09-02       Impact factor: 7.446

5.  The inhibitory effects of mitragynine on P-glycoprotein in vitro.

Authors:  Noradliyanti Rusli; Azimah Amanah; Gurjeet Kaur; Mohd Ilham Adenan; Shaida Fariza Sulaiman; Habibah Abdul Wahab; Mei Lan Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-02       Impact factor: 3.000

6.  Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids.

Authors:  Samuel Obeng; Shyam H Kamble; Morgan E Reeves; Luis F Restrepo; Avi Patel; Mira Behnke; Nelson J-Y Chear; Surash Ramanathan; Abhisheak Sharma; Francisco León; Takato Hiranita; Bonnie A Avery; Lance R McMahon; Christopher R McCurdy
Journal:  J Med Chem       Date:  2019-12-27       Impact factor: 7.446

7.  Lateral Flow Assessment and Unanticipated Toxicity of Kratom.

Authors:  Lauren C Smith; Lucy Lin; Candy S Hwang; Bin Zhou; Diane M Kubitz; Huiying Wang; Kim D Janda
Journal:  Chem Res Toxicol       Date:  2018-11-16       Impact factor: 3.739

8.  Pharmacokinetics of mitragynine in man.

Authors:  Satariya Trakulsrichai; Korbtham Sathirakul; Saranya Auparakkitanon; Jatupon Krongvorakul; Jetjamnong Sueajai; Nantida Noumjad; Chonlaphat Sukasem; Winai Wananukul
Journal:  Drug Des Devel Ther       Date:  2015-04-29       Impact factor: 4.162

Review 9.  Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom.

Authors:  Dimy Fluyau; Neelambika Revadigar
Journal:  Front Psychiatry       Date:  2017-04-24       Impact factor: 4.157

Review 10.  The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.

Authors:  Jack E Henningfield; Reginald V Fant; Daniel W Wang
Journal:  Psychopharmacology (Berl)       Date:  2017-12-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.